Global Type I Borosilicate Pharmaceutical Glass Tubing Market Strategic Research Report

Scope of the Report

The global Type I Borosilicate Pharmaceutical Glass Tubing market size is predicted to grow from US$ 3,913 million in 2025 to US$ 6,458 million in 2032; it is expected to grow at a CAGR of 7.2% from 2026 to 2032.

In 2025, global sales of Type I borosilicate pharmaceutical glass tubing were approximately 500 thousand tons, with an average price of about US$8,000 per ton, corresponding to a market size of approximately US$4.0 billion. Type I borosilicate pharmaceutical glass tubing is an upstream pharmaceutical glass tubing material made from highly hydrolytic resistant borosilicate glass through melting, tube drawing, and precision dimensional control processes. It is used to manufacture high-end injectable packaging containers such as vials, ampoules, pharmaceutical glass cartridges, and prefillable syringe barrels. These products typically feature Type I hydrolytic resistance, low extractables, high chemical stability, good thermal stability, and tight dimensional consistency. Key parameters include outer diameter, wall thickness, ovality, straightness, coefficient of thermal expansion, inner surface quality, and particle control level.

The growth of pharmaceutical glass cartridges is mainly driven by the long-term shift toward injectable therapies, self-administration and higher-value drug delivery formats. Diabetes and metabolic disease treatment remains the most stable demand base, supported by insulin, GLP-1 and other metabolic injectable therapies. Dental local anesthesia provides a high-frequency and standardized demand segment, while growth and fertility treatments and other chronic self-injection therapies further support demand for small-volume, high-precision glass cartridges. Leading suppliers increasingly position glass cartridges as a critical interface between primary packaging and drug delivery systems, as Stevanato highlights their use in pen injectors, auto-injectors and on-body delivery systems.

From a product perspective, the industry is moving beyond standard bulk cartridges toward higher-precision, ready-to-use, large-volume and dual-chamber formats. Standard single-chamber cartridges still represent the mainstream product base, but RTU cartridges, nest-and-tub packaging, large-volume cartridges and dual-chamber cartridges carry higher technical barriers and stronger value-added potential. SCHOTT Pharma’s cartriQ Large Volume platform targets wearable injection devices and long-duration large-volume subcutaneous delivery, while dual-chamber cartridges are designed for lyophilized drug reconstitution and sequential administration, making them suitable for sensitive biologics, peptide drugs and complex injectable formulations.

The competitive landscape is characterized by strong global leaders and selective regional expansion. Gerresheimer discloses annual production of more than one billion glass cartridges, indicating that leading suppliers already operate at billion-unit scale. SCHOTT Pharma, Stevanato, Gerresheimer and Nipro have clear advantages in pharmaceutical glass know-how, dimensional control, RTU processing, global pharmaceutical customer qualification and compatibility with advanced delivery systems. Chinese manufacturers are benefiting from the upgrade toward Type I borosilicate pharmaceutical packaging and domestic substitution in prefillable and cartridge formats, but they still need to build stronger capabilities in high-end RTU cartridges, dual-chamber designs, large-volume formats and international pharmaceutical supply chain qualification.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Type I Borosilicate Pharmaceutical Glass Tubing market?

What factors are driving Type I Borosilicate Pharmaceutical Glass Tubing market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Type I Borosilicate Pharmaceutical Glass Tubing market opportunities vary by end market size?

How does Type I Borosilicate Pharmaceutical Glass Tubing break out by Type, by Application?

This report presents a comprehensive overview of the global Type I Borosilicate Pharmaceutical Glass Tubing market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• 5.0 Clear Neutral Borosilicate Pharmaceutical Glass Tubing
• 5.0 Amber Neutral Borosilicate Pharmaceutical Glass Tubing
• 3.3 Borosilicate Pharmaceutical Glass Tubing
• Other

Segment by Outer Diameter Range

• 6.0 mm to Less than 20.0 mm
• 20.0 mm to Less than 28.0 mm
• 28.0 mm to 32.0 mm
• Other

Segment by Application

• Glass Tubing for Vials
• Glass Tubing for Ampoules
• Glass Tubing for Cartridges
• Glass Tubing for Prefillable Syringes
• Other

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Type I Borosilicate Pharmaceutical Glass Tubing market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Glass Tubing for Vials, Glass Tubing for Ampoules, Glass Tubing for Cartridges evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact